APP
Alternative Names: Amyloid beta A4 protein, ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, APP, A4, AD1, AAA, PN2, ABETA, CTFgamma.
- Sku: PSB-pro-1080-5µg
- Vendor: ProSpec-Tany
Contact us directly for international purchases.
Product Description
Recombinant Human Amyloid beta (A4) Precursor Protein is a protein encoded by the APP gene in humans. Belonging to the amyloid precursor protein family, it plays a significant role in the pathogenesis of Alzheimer's disease. This protein is involved in the production of amyloid-beta peptides, which are known to accumulate and form plaques in the brains of individuals affected by Alzheimer's disease. With a molecular weight of approximately 110 kDa, Recombinant Human Amyloid beta (A4) Precursor Protein serves as a crucial research tool for studying the mechanisms underlying neurodegenerative disorders.
Current Lead Time
7-14 Days
Product Specifications
Species |
Human |
Expression System | E. coli |
Purity | 85.0% by SDS-PAGE |
Activity |
Not Available |
Activity Assay | |
Animal Component Free (ACF) | Yes |
Molecular Weight |
34.7 kDa |
Structure | Monomer |
Endotoxin Concentration |
Not Available |
Purification Method | Not Available |
Form |
Frozen |
Formulation | APP protein solution (0.5mg/ml) containing 20mM Tris-HCl buffer (pH8.0), 20% glycerol, 0.1M NaCl and 1mM DTT. |
*For Research Use Only
If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation.
Have a question?
APP